GoAI
Get started
FB Care Service Co.,Ltd. logo

FB Care Service Co.,Ltd.

9220.T

JPXHealthcareMedical - Care Facilities

Open in GoAI

Latest quote

¥1,258

+¥14.00 · +1.13%

Aug 24, 3:30 PM JST

9220.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Founded in 1987 and headquartered in Saku, Japan, FB Care Service Co.,Ltd. delivers a broad array of elder care solutions, operating both within Japan and on an international scale. The company's activities are divided into two primary divisions: direct nursing and welfare equipment. Within its care offerings, FB Care Service manages various facilities, including private, fee-based nursing homes and community-based group residences. It also provides specialized integrated small-scale home and nursing support, daily activity programs, at-home personal care and medical visits, and guidance for in-home care arrangements. Furthermore, the company assists clients by renting and selling essential assistive devices.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
JP
CEO
Miho Yanagizawa
Listed since
Apr 7, 2022
Employees
993

Market position

52-week range

Current ¥1,258

Open
¥1,258
Previous close
¥1,244
Volume
1.5K
0.61× average
Average volume
2.45K
Average daily volume
Market cap
3.07B JPY
Beta
0.37
Market reference 1
50-day average
¥1,219.88
+3.12% above average
200-day average
¥1,216.37
+3.42% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
3.36B JPY
EV / EBITDA
3.2×
Earnings yield
15.53%
Free cash flow yield
37.67%

Profitability & efficiency

Return on equity
11.53%
Return on assets
4.85%
Return on invested capital
5.46%

Financial health

Current ratio
1.63×
Altman Z-score
2.49
Piotroski F-score
6 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends18%13%8%2%Gross margin, FY2021: 16.95%Gross margin, FY2022: 16.15%Gross margin, FY2023: 14.36%Gross margin, FY2024: 15.47%Gross margin, FY2025: 15.43%Operating margin, FY2021: 7.07%Operating margin, FY2022: 5.66%Operating margin, FY2023: 5.09%Operating margin, FY2024: 6.01%Operating margin, FY2025: 5.50%Net margin, FY2021: 5.76%Net margin, FY2022: 4.63%Net margin, FY2023: 5.05%Net margin, FY2024: 3.71%Net margin, FY2025: 3.92%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 16.95%. Gross margin FY2022 16.15%. Gross margin FY2023 14.36%. Gross margin FY2024 15.47%. Gross margin FY2025 15.43%. Operating margin FY2021 7.07%. Operating margin FY2022 5.66%. Operating margin FY2023 5.09%. Operating margin FY2024 6.01%. Operating margin FY2025 5.50%. Net margin FY2021 5.76%. Net margin FY2022 4.63%. Net margin FY2023 5.05%. Net margin FY2024 3.71%. Net margin FY2025 3.92%.

Income trends

Revenue

11.53B JPY+5.16%

Operating income

634.4M JPY-3.83%

Net income

451.6M JPY+11.13%
Income trends across reported periods12.65B JPY8.2B JPY3.74B JPY−706.4M JPYRevenue, FY2021: 9.19B JPYRevenue, FY2022: 9.62B JPYRevenue, FY2023: 10.36B JPYRevenue, FY2024: 10.97B JPYRevenue, FY2025: 11.53B JPYOperating income, FY2021: 649.52M JPYOperating income, FY2022: 544.27M JPYOperating income, FY2023: 527.4M JPYOperating income, FY2024: 659.68M JPYOperating income, FY2025: 634.4M JPYNet income, FY2021: 528.7M JPYNet income, FY2022: 444.93M JPYNet income, FY2023: 523.43M JPYNet income, FY2024: 406.36M JPYNet income, FY2025: 451.6M JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 9.19B JPY. Revenue FY2022 9.62B JPY. Revenue FY2023 10.36B JPY. Revenue FY2024 10.97B JPY. Revenue FY2025 11.53B JPY. Operating income FY2021 649.52M JPY. Operating income FY2022 544.27M JPY. Operating income FY2023 527.4M JPY. Operating income FY2024 659.68M JPY. Operating income FY2025 634.4M JPY. Net income FY2021 528.7M JPY. Net income FY2022 444.93M JPY. Net income FY2023 523.43M JPY. Net income FY2024 406.36M JPY. Net income FY2025 451.6M JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue11.53B JPY10.97B JPY10.36B JPY9.62B JPY9.19B JPY
Cost of goods sold9.75B JPY9.27B JPY8.87B JPY8.07B JPY7.63B JPY
Gross profit1.78B JPY1.7B JPY1.49B JPY1.55B JPY1.56B JPY
Selling, general, and administrative1.15B JPY765.31M JPY703.25M JPY764.69M JPY684.53M JPY
Operating expenses1.15B JPY1.04B JPY960.69M JPY1.01B JPY907.36M JPY
Interest income6.41M JPY2.58M JPY1.41M JPY1.23M JPY1.06M JPY
Interest expense31.62M JPY32.59M JPY33.99M JPY36.77M JPY42.53M JPY
Depreciation and amortization416.13M JPY396.73M JPY372.91M JPY319.2M JPY314.03M JPY
Operating income634.4M JPY659.68M JPY527.4M JPY544.27M JPY649.52M JPY
Net income451.6M JPY406.36M JPY523.43M JPY444.93M JPY528.7M JPY

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
52.51

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates66.147.9129.7111.52Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 14, 2024: actual 38.25, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 14, 2025: actual 44.17, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 15, 2025: actual 28.27, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 8, 2025: actual 53.32, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 14, 2025: actual 53.23, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 13, 2026: actual 62.21, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 15, 2026: actual 13.55, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 10, 2026: actual 52.51, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly Revenue actual values compared with estimates3.11B2.94B2.77B2.6BQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 14, 2024: actual 2.76B JPY, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 14, 2025: actual 2.79B JPY, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 15, 2025: actual 2.72B JPY, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 8, 2025: actual 2.82B JPY, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 14, 2025: actual 2.88B JPY, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 13, 2026: actual 2.94B JPY, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 15, 2026: actual 2.89B JPY, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 10, 2026: actual 2.99B JPY, estimate —, surprise —, Comparison unavailable.

9220.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥6,987

-0.34%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,797

+0.57%

HOYA Corporation logo

7741.T

HOYA Corporation

¥24,895

0.00%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,210

+0.12%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,858

+0.86%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,406.5

+0.82%

Continue in GoAI

Research 9220.T

research.disclaimer